Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.840
-0.120 (-2.42%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $9.30 million as of April 28, 2026. Its market cap has decreased by -24.43% in one year.
Market Cap
9.30M
Enterprise Value
4.85M
1-Year Change
-24.43%
Ranking
Category
Stock Price
$4.84
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $9.30M, a decrease of -98.65%. That is a compound annual growth rate of -56.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 9.53M | -9.19% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 10.52M |
| Kiora Pharmaceuticals | 10.18M |
| Enveric Biosciences | 10.13M |
| Aprea Therapeutics | 9.86M |
| Quoin Pharmaceuticals | 9.85M |
| Evogene | 9.67M |
| CalciMedica | 9.29M |
| NuCana | 9.20M |